Femoral Artery News and Research

RSS

DMC CVI completes the first two transcatheter aortic valve implants in Michigan

The Detroit Medical Center (DMC) Cardiovascular Institute (CVI) has completed the first two transcatheter aortic valve implants (TAVI) ever achieved in Michigan. The procedures are a part of CVI's participation in the Medtronic CoreValve® U.S. Clinical Trial. This multi-state trial will evaluate a new, non-surgical alternative to open-heart surgery for patients with severe aortic stenosis.

2 Mar 2011

Investigational heart valve implanted in patient through small puncture hole in leg

Physicians at the Methodist DeBakey Heart & Vascular Center in Houston implanted a new investigational heart valve in a patient through a small puncture hole in the leg.

21 Feb 2011

FDA approves GORE VIABAHN device to treat peripheral artery disease

W. L. Gore & Associates today announced it has received FDA approval for the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface on a lower profile delivery system.

17 Feb 2011

IDEV announces release of SUPERA stent data from Leipzig Registry

IDEV Technologies, Incorporated, an innovative leader in the development and commercialization of minimally invasive medical technologies, today announced the release of two-year European data from the prominent Leipzig Registry, which tracks patients treated with the SUPERA wire interwoven nitinol stent.

27 Jan 2011

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

The Methodist DeBakey Heart & Vascular Center was chosen today as a site for a critical percutaneous heart valve study. As part of the research study, Methodist physicians will replace diseased cardiac valves through a single, tiny puncture hole in the research subject's groin.

24 Jan 2011

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease (PAD) who undergo an angioplasty and stent procedure in the superficial femoral artery.

21 Jan 2011

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

Pervasis Therapeutics, Inc. today announced that the company is pursuing a matrix-embedded endothelial cell-based therapy (PVS-30200) to target and regulate cell stroma (the tumor environment or "ecosystem" that is comprised of various supporting cell types distinct from cancer cells) in order to prevent key processes that play a role in advancing solid tumor growth and metastasis.

20 Jan 2011

New GORE VIABAHN Endoprosthesis is now available in Europe

W. L. Gore & Associates today announced the European availability of the GORE VIABAHN Endoprosthesis on a lower profile delivery system. The announcement came during the Leipzig Interventional Course in Germany, where European interventionalists gathered to discuss new approaches in treating patients suffering from peripheral artery disease.

19 Jan 2011

Medtronic recieves conditional approval from FDA to modify CoreValve U.S. Pivotal Clinical Trial

Medtronic, today announced it has received conditional approval from the U.S. Food and Drug Administration to modify its CoreValve U.S. Pivotal Clinical Trial.

19 Jan 2011

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

Hotspur Technologies, announced today that Dr. Greg Sampognaro, Interventional Cardiologist at P & S Surgical Hospital in Monroe, Louisiana, successfully completed the first use of the GPSCath Balloon Dilatation Catheter in an intervention to treat a blocked peripheral artery.

18 Jan 2011

EverFlex+ Self-Expanding Peripheral Stent System is now available in Europe

Covidien, a leading global provider of healthcare products, today announced availability of the EverFlex+™ Self-Expanding Peripheral Stent System in Europe.

18 Jan 2011

AccessClosure launches Mynx Cadence Vascular Closure Device

AccessClosure, the U.S. market leader in extravascular closure devices, announced today the launch of its next generation product, the Mynx Cadence Vascular Closure Device.

11 Jan 2011

St. Luke’s second in nation to perform EVAR with Endurant AAA Stent Graft System

An 80-year-old patient at St. Luke's Episcopal Hospital (St. Luke's) in Houston became the second in the nation to be treated with a newly approved FDA device for an abdominal aortic aneurysm (AAA). The condition, often called, "the silent killer," is a dangerous bulge or ballooning in the main artery of the body that typically causes no symptoms until it ruptures.

23 Dec 2010

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

David H. Adams, MD, Marie-Jos-e and Henry R. Kravis Professor and Chairman of the Department of Cardiothoracic Surgery, Samin K. Sharma, MD, the Zena and Michael A. Weiner Professor and Director of the Cardiac Catheterization Laboratory, and Annapoorna S. Kini, MD, Associate Professor and Associate Director of the Cardiac Catheterization Laboratory at The Mount Sinai Medical Center, have performed the first implantation of the Medtronic CoreValve- Transcatheter Aortic Valve Prosthesis in the United States.

22 Dec 2010

U.S. pivotal clinical trial of Medtronic CoreValve begins

Medtronic, Inc. today announced the beginning of its Medtronic CoreValve® U.S. Pivotal clinical trial in the United States. The first CoreValve transcatheter aortic valve implantation (TAVI) procedure was performed by David H. Adams, M.D., and Samin K. Sharma, M.D., at The Mount Sinai Medical Center in New York City.

22 Dec 2010

El Camino announces first patient implant in Medtronic CoreValve clinical trial

El Camino Hospital today announced its first patient implant in the Medtronic CoreValve® U.S. Clinical Trial.

22 Dec 2010

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Bioheart, Inc. announced today that at the American Heart Association Annual Meeting, it finalized the formation of a working group. The group's focus is to advance a BRIDGE TO RECOVERY clinical trial, combining a left ventricle assist device (LVAD) and Bioheart's MyoCell adult muscle stem cell composition and Bioheart's MyoCath needle tipped catheter delivery system.

9 Dec 2010

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists from the Mayo Clinic performed sheathless transradial percutaneous coronary intervention (PCI) to remedy complex lesions, achieving a 90% success rate with no radial complications. Standard guiding catheters were used during the procedure. Details of this novel approach—overcoming the last hurdle to greater adoption of transradial PCI in the U.S.—are published in the December issue of Catheterization and Cardiovascular Intervention, the official journal of The Society for Cardiovascular Angiography and Interventions.

7 Dec 2010

Cardiologists achieve 90% success rate in sheathless transradial PCI to remedy complex lesions

7 Dec 2010

Angiotech reports $59.0 million total revenue for third quarter 2010

Angiotech Pharmaceuticals, Inc. today announced that it had released its financial results for the third quarter ended September 30, 2010.

9 Nov 2010

Femoral Artery News and Research

DMC CVI completes the first two transcatheter aortic valve implants in Michigan

Investigational heart valve implanted in patient through small puncture hole in leg

FDA approves GORE VIABAHN device to treat peripheral artery disease

IDEV announces release of SUPERA stent data from Leipzig Registry

Methodist DeBakey Heart & Vascular Center chosen for critical percutaneous heart valve study

Pervasis to present PVS-10200 interim data from Phase 1/2 PAD clinical study at IC3D

Pervasis pursues matrix-embedded endothelial cell-based therapy to target and regulate cell stroma

New GORE VIABAHN Endoprosthesis is now available in Europe

Medtronic recieves conditional approval from FDA to modify CoreValve U.S. Pivotal Clinical Trial

Hotspur announces successful completion of GPSCath Catheter in peripheral angioplasty surgery

EverFlex+ Self-Expanding Peripheral Stent System is now available in Europe

AccessClosure launches Mynx Cadence Vascular Closure Device

St. Luke’s second in nation to perform EVAR with Endurant AAA Stent Graft System

First implantation of Medtronic Transcatheter Aortic Valve Prosthesis in US performed at Mount Sinai

U.S. pivotal clinical trial of Medtronic CoreValve begins

El Camino announces first patient implant in Medtronic CoreValve clinical trial

Bioheart group to advance BRIDGE TO RECOVERY clinical trial

Sheathless transradial intervention highly successful in treating complex lesions

Cardiologists achieve 90% success rate in sheathless transradial PCI to remedy complex lesions

Angiotech reports $59.0 million total revenue for third quarter 2010

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News